Yoon, Bora
Lee, Hyuk-je
Kim, Woojun
Shim, Yong Soo
Lim, Eun Ye
Cho, A-Hyun
Song, In Wook
Hong, Yun Jeong
Shin, Hye Eun
Ku, Bon D.
Cho, Soo Hyun
Ku, Hyejin
Shin, Dong-Hoon
Yang, Dong Won https://orcid.org/0000-0002-4733-7298
Funding for this research was provided by:
Korea Institute for Advancement of Technology (P0018061)
Ministry of Health and Welfare (HI18C0530)
Aible Therapeutics Co., Ltd.
Article History
Received: 13 September 2025
Accepted: 6 November 2025
First Online: 3 January 2026
Declarations
:
: Ethics approval for this study was obtained from the Institutional Review Board of Seoul St. Mary’s Hospital, The Catholic University of Korea (IRB No. XC24DDDS0008), and the study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent.
: Woojun Kim is a co-founder and shareholder of Aible Therapeutics Co., Ltd., which developed SPICK, the application used in this study. Hyejin Ku and Dong-Hoon Shin are employees of company Aible Therapeutics Co., Ltd. The other authors declare that they have no competing interests.